Maria Dąbkowska

Maria Dąbkowska

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
MDMaria Dąbkowska
Maria Dąbkowska
ZAZbigniew Adamczyk
Zbigniew Adamczyk

1 March 2018 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
ZAZbigniew Adamczyk
Zbigniew Adamczyk
MNMałgorzata Nattich-Rak
Małgorzata Nattich-Rak
MDMaria Dąbkowska
Maria Dąbkowska
MKMarta Kujda-Kruk
Marta Kujda-Kruk

1 January 2013 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MDMaria Dąbkowska
Maria Dąbkowska
ZAZbigniew Adamczyk
Zbigniew Adamczyk
MKMarta Kujda
Marta Kujda

31 August 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MDMaria Dąbkowska
Maria Dąbkowska
KŁKarolina Łuczkowska
Karolina Łuczkowska
DRDorota Rogińska
Dorota Rogińska
ASAnna Sobuś
Anna Sobuś
Monika WasilewskaMonika Wasilewska
Monika Wasilewska
BMBogusław Machaliński
Bogusław Machaliński
Brain-derived neurotrophic factor (BDNF) is essential for the development and function of human neurons, therefore it is a promising target for neurodegenerative disorders treatment. Here, we studied BDNF-based electrostatic complex with dendrimer nanoparticles encapsulated in polyethylene glycol (PEG) in neurotoxin-treated, differentiated neuroblastoma SH-SY5Y cells, a model of neurodegenerative mechanisms. PEG layer was adsorbed at dendrimer-protein core nanoparticles to decrease their cellular uptake and to reduce BDNF-other proteins interactions for a prolonged time. Cytotoxicity and confocal microscopy analysis revealed PEG-ylated BDNF-dendrimer nanoparticles can be used for continuous neurotrophic factor delivery to the neurotoxin-treated cells over 24 h without toxic effect. We offer a reliable electrostatic route for efficient encapsulation and controlled transport of fragile therapeutic proteins without any covalent cross-linker; this could be considered as a safe drug delivery system. Understanding the polyvalent BDNF interactions with dendrimer core nanoparticles offers new possibilities for design of well-ordered protein drug delivery systems.

1 August 2011 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
MDMaria Dąbkowska
Maria Dąbkowska
ZAZbigniew Adamczyk
Zbigniew Adamczyk
JBJakub Barbasz
Jakub Barbasz

25 October 2012 in Langmuir
Verified
Journal Article
Closed access
MDMaria Dąbkowska
Maria Dąbkowska
ZAZbigniew Adamczyk
Zbigniew Adamczyk